Burrell Terry-Ann
SEC CIK 1786484 · EDGAR
BoughtSold
Most active insiders at RXRX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Borgeson Blake | Dir | — | $4.10M |
| 2 | Gibson Christopher | Dir | — | $3.84M |
| 3 | Khan Najat | Chief R, D Commercial Off, Dir | — | $806.7K |
| 4 | Taylor Ben R | CFO | — | $157.7K |
| 5 | Bumpus Namandje | Dir | — | $28.1K |
| 6 | Michor Franziska | Dir | — | — |
| 7 | Hallett David | CSO | — | — |
| 8 | Dar Zavain | Dir | — | — |
| 9 | Li Dean Y | Dir | — | — |
| 10 | Sun Elaine D | Dir | — | — |
Burrell Terry-Ann made no open-market trades at RXRX in the last 12 months.
Transactions 28
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-07-03 | 2024-07-01 | RXRX | RECURSION PHARMACEUTICALS, INC. | Burrell Terry-Ann | Dir | A - Grant | $0.00 | +1,843 | 71.3K | +3% | $0 | |
| D | 2024-06-05 | 2024-06-03 | RXRX | RECURSION PHARMACEUTICALS, INC. | Burrell Terry-Ann | Dir | A - Grant | $0.00 | +13.1K | 69.4K | +23% | $0 |
| D | 2024-04-29 | 2024-04-26 | BEAM | Beam Therapeutics Inc. | Burrell Terry-Ann | CFO | A - Grant | $0.00 | +12.5K | 82.6K | +18% | $0 |
| 2024-04-03 | 2024-04-01 | RXRX | RECURSION PHARMACEUTICALS, INC. | Burrell Terry-Ann | Dir | A - Grant | $0.00 | +1,467 | 56.3K | +3% | $0 | |
| T | 2024-04-03 | 2024-04-01 | BEAM | Beam Therapeutics Inc. | Burrell Terry-Ann | CFO | S - Sale | $32.12 | -5,446 | 70.1K | -7% | -$174.9K |
| 2024-04-02 | 2024-03-31 | BEAM | Beam Therapeutics Inc. | Burrell Terry-Ann | CFO | A - Grant | $0.00 | +27.5K | 75.6K | +57% | $0 | |
| M | 2023-07-14 | 2023-07-12+ | RXRX | RECURSION PHARMACEUTICALS, INC. | Burrell Terry-Ann | Dir | S - Sale | $12.07 | -117.0K | 69.5K | -63% | -$1.41M |
| D | 2023-06-21 | 2023-06-16 | RXRX | RECURSION PHARMACEUTICALS, INC. | Burrell Terry-Ann | Dir | A - Grant | $0.00 | +12.6K | 171.8K | +8% | $0 |
| M | 2023-04-05 | 2023-04-03+ | BEAM | Beam Therapeutics Inc. | Burrell Terry-Ann | CFO | S - Sale | $29.74 | -4,640 | 47.1K | -9% | -$138.0K |
| D | 2023-03-31 | 2023-03-31 | BEAM | Beam Therapeutics Inc. | Burrell Terry-Ann | CFO | A - Grant | $0.00 | +20.0K | 51.3K | +64% | $0 |
| DM | 2023-01-30 | 2023-01-26+ | BEAM | Beam Therapeutics Inc. | Burrell Terry-Ann | CFO | M - OptEx | $13.68 | +37.3K | 67.4K | +123% | +$509.6K |
| DM | 2023-01-30 | 2023-01-26+ | BEAM | Beam Therapeutics Inc. | Burrell Terry-Ann | CFO | S - Sale+OE | $45.08 | -37.3K | 31.3K | -54% | -$1.68M |
| DM | 2023-01-25 | 2023-01-23+ | BEAM | Beam Therapeutics Inc. | Burrell Terry-Ann | CFO | S - Sale+OE | $45.01 | -20.2K | 31.3K | -39% | -$910.9K |
| DM | 2023-01-25 | 2023-01-23+ | BEAM | Beam Therapeutics Inc. | Burrell Terry-Ann | CFO | M - OptEx | $13.68 | +20.2K | 36.7K | +123% | +$276.8K |
| D | 2023-01-20 | 2023-01-18 | BEAM | Beam Therapeutics Inc. | Burrell Terry-Ann | CFO | M - OptEx | $13.68 | +39.9K | 78.5K | +103% | +$545.6K |
| D | 2023-01-20 | 2023-01-18 | BEAM | Beam Therapeutics Inc. | Burrell Terry-Ann | CFO | S - Sale+OE | $45.14 | -47.2K | 31.3K | -60% | -$2.13M |
| 2023-01-05 | 2023-01-03 | RXRX | RECURSION PHARMACEUTICALS, INC. | Burrell Terry-Ann | Dir | A - Grant | $0.00 | +1,821 | 159.2K | +1% | $0 | |
| 2022-10-05 | 2022-10-03 | RXRX | RECURSION PHARMACEUTICALS, INC. | Burrell Terry-Ann | Dir | A - Grant | $0.00 | +1,265 | 157.4K | +0.8% | $0 | |
| 2022-07-06 | 2022-07-01 | RXRX | RECURSION PHARMACEUTICALS, INC. | Burrell Terry-Ann | Dir | A - Grant | $0.00 | +1,631 | 156.1K | +1% | $0 | |
| D | 2022-06-16 | 2022-06-14 | RXRX | RECURSION PHARMACEUTICALS, INC. | Burrell Terry-Ann | Dir | A - Grant | $0.00 | +18.1K | 154.5K | +13% | $0 |
| 2022-04-05 | 2022-04-01 | RXRX | RECURSION PHARMACEUTICALS, INC. | Burrell Terry-Ann | Dir | A - Grant | $0.00 | +1,788 | 136.4K | +1% | $0 | |
| 2022-04-04 | 2022-03-31 | BEAM | Beam Therapeutics Inc. | Burrell Terry-Ann | CFO | S - Sale | $59.11 | -1,787 | 38.3K | -4% | -$105.6K | |
| 2022-04-04 | 2022-03-31 | BEAM | Beam Therapeutics Inc. | Burrell Terry-Ann | CFO | A - Grant | $0.00 | +15.0K | 40.1K | +60% | $0 | |
| 2022-01-05 | 2022-01-03 | RXRX | RECURSION PHARMACEUTICALS, INC. | Burrell Terry-Ann | Dir | A - Grant | $0.00 | +763 | 134.6K | +0.6% | $0 | |
| 2021-10-05 | 2021-10-01 | RXRX | RECURSION PHARMACEUTICALS, INC. | Burrell Terry-Ann | Dir | A - Grant | $0.00 | +629 | 133.8K | +0.5% | $0 | |
| 2021-07-06 | 2021-07-01 | RXRX | RECURSION PHARMACEUTICALS, INC. | Burrell Terry-Ann | Dir | A - Grant | $0.00 | +382 | 133.2K | +0.3% | $0 | |
| DM | 2021-07-02 | 2021-06-30 | BEAM | Beam Therapeutics Inc. | Burrell Terry-Ann | CFO | S - Sale+OE | $122.00 | -30.0K | 39.8K | -43% | -$3.66M |
| D | 2021-07-02 | 2021-06-30 | BEAM | Beam Therapeutics Inc. | Burrell Terry-Ann | CFO | M - OptEx | $13.68 | +30.0K | 54.8K | +121% | +$410.4K |
Purchase Sale Sale after option exercise All abbreviations